High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy

Journal of Viral Hepatitis

Volumn 19, Issue 8, 2012, Pages 547-553

  Biermer, M ^a,b   Schlosser, B ^c   Fulop B ^a   Van Bommel F ^a   Brodzinski, A ^a   Heyne, R ^b   Keller, K ^d   Sarrazin, C ^d   Berg, Thomas ^a,c  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Leber und Studienzentrum Am Checkpoint   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

hepatitis C; incomplete response; nonresponse; partial response; rescue treatment; silibinin; SVR; treatment enhancement

Indexed keywords

LEGALON SIL; METOCLOPRAMIDE; PEGINTERFERON ALPHA2A; RIBAVIRIN; SILIBININ; UNCLASSIFIED DRUG; VIRUS RNA;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ABDOMINAL PERISTALSIS; ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEAT SENSATION; HEPATITIS C; HUMAN; MALE; NAUSEA; PERISTALSIS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT RESPONSE; VIREMIA; VIROLOGY; VOMITING;

ADULT; AGED; ANTIOXIDANTS; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INFUSIONS, INTRAVENOUS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RIBAVIRIN; SILYMARIN; TREATMENT OUTCOME; VIREMIA;

EID: 84863720486     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01572.x     Document Type: Article

References (15)

1. Saller R, Brignoli R, Melzer J, Meier R,. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementärmed 2008; 15: 9-20.
2. El-Zayadi AR, Attia M, Badran HM, et al. Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy. Liver Int 2005; 25 (4): 746-751.
3. Gordon A, Hobbs DA, Bowden DS, et al. Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C. J Gastroenterol Hepatol 2006; 21 (1 Pt 2): 275-280.
4. Hruby K, Csomos G, Fuhrmann M, Thaler H,. Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. Hum Toxicol 1983; 2 (2): 183-195.
5. Ferenci P, Scherzer TM, Kerschner H, et al. Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy. Gastroenterology 2008; 135: 1561-1567.
6. Ahmed-Belkacem A, Ahnou N, Barbotte L, et al. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Gastroenterology 2010; 138 (3): 1112-1122.
7. Wagoner J, Negash A, Kane OJ, et al. Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology 2010; 51 (6): 1912-1921.
8. Sarrazin C, Berg T, Ross RS, et al. [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol 2010; 48 (2): 289-351.
9. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55 (2): 245-264.
10. Lucidarme D, Foucher J, Le Bail B, et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49 (4): 1083-1089.
11. Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134 (4): 960-974.
12. Jacobson IM, McHutchison JG, Dusheiko G, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364 (25): 2405-2416.
13. Poordad F, McCone Jr J, Bacon BR, et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364 (13): 1195-1206.
14. Sarrazin C, Zeuzem S,. Resistance to direct antiviral agents in patients with hepatitis C virus infection. Gastroenterology 2010; 138 (2): 447-462.
15. Rutter K, Beinhardt S, Kerschner H, et al. Intravenous silibinin as "rescue treatment" for on treatment nonresponders to full dose of peginterferon/ribavirin combination therapy. J Hepatol 2009; 50 (Suppl. 1): S235-S236.